Skip to main content

Spondyloarthritis

      Late-Breaking Trials in axSpA and PsA
      Drs. Jack Cush & Arthur Kavanaugh, two of rheumatology’s most trusted voices, provide a breakdown of the latest breakthroughs and hottest topics in rheumatology from the 2025 ACR Convergence meeting in Chicago.
      Rheumatology Roundup
      #ACR25 Sheds Light on Disparities, Age-Related Trends, and Epidemiology in Autoimmune Rheumatic Diseases At #ACR25, ne

      Dr. John Cush RheumNow

      3 days 9 hours ago

      #ACR25 Sheds Light on Disparities, Age-Related Trends, and Epidemiology in Autoimmune Rheumatic Diseases At #ACR25, new research explored critical disparities and epidemiologic trends shaping outcomes in autoimmune rheumatic diseases across diverse populations and age groups. https://t.co/CPob0ppjv3

      Sexual Function in axSpA
      Ankylosing spondylitis (AS) is a burden on the bones—both literally and diagnostically. The disease’s dual nature, marked by chronic inflammation and abnormal new bone formation, complicates the assessment of bone health. While inflammation erodes trabecular bone, syndesmophytes and ligamentous calcifications can falsely elevate spine bone mineral density (BMD) readings on standard dual-energy X-ray absorptiometry (DXA).
      New Insights into Pregnancy Outcomes and Maternal-Fetal Health in Rheumatic Diseases

      At #ACR25, the ACR presented new

      Dr. John Cush RheumNow

      4 days 16 hours ago
      New Insights into Pregnancy Outcomes and Maternal-Fetal Health in Rheumatic Diseases At #ACR25, the ACR presented new research illuminating critical challenges and advances in pregnancy outcomes for women living with rheumatic diseases, including axial spondyloarthritis, https://t.co/nJjtTMHnD3
      What happens if you have #axSpA & concomitant #FM?

      Pts with both have less TNFi retention,
      -residual pain may lead

      Janet Pope Janetbirdope

      4 days 19 hours ago
      What happens if you have #axSpA & concomitant #FM? Pts with both have less TNFi retention, -residual pain may lead to d/c Rx. Need to determine if axSpA pt has #fibromyalgia as there may not be objective findings if no peripheral arthritis in axSpA. #ACR25 @RheumNow abst#534
      Coping Strategies in axSpA
      In AxSpA, an 8-week personalized exercise program improved trunk strength (+14.1%), mobility (+14.9%), and cardiorespira

      Antoni Chan MD (Prof) synovialjoints

      5 days 14 hours ago
      In AxSpA, an 8-week personalized exercise program improved trunk strength (+14.1%), mobility (+14.9%), and cardiorespiratory fitness ( increased oxygen pulse, ventilatory efficiency, anaerobic threshold). BASDAI and chest expansion also improved. Supports tailored rehab based on https://t.co/jawosa2AJK
      In early axSpA vs non-axSpA CBP, 2 year spinal x-ray progression was minimal in both groups. But on MRI, fat lesions inc

      Antoni Chan MD (Prof) synovialjoints

      5 days 16 hours ago
      In early axSpA vs non-axSpA CBP, 2 year spinal x-ray progression was minimal in both groups. But on MRI, fat lesions increased significantly in axSpA (0.16 units/yr vs –0.02), with 15% having ≥3 lesions at 2 year vs 1% in non-axSpA. Fat lesions may signal early structural https://t.co/zvgU1Gt0po
      ×